BSE Live
Feb 03, 14:46Prev. Close
358.35
Open Price
362.65
Bid Price (Qty.)
364.20 (7)
Offer Price (Qty.)
367.95 (54)
NSE Live
Feb 03, 14:46Prev. Close
361.20
Open Price
374.90
Bid Price (Qty.)
365.95 (1)
Offer Price (Qty.)
366.75 (4)
| Key Financial Ratios of Medicamen Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 7.43 | 10.50 | 12.04 | 12.20 | 10.22 | |
| Diluted EPS (Rs.) | 7.43 | 10.50 | 12.04 | 12.20 | 10.22 | |
| Cash EPS (Rs.) | 12.91 | 15.97 | 16.88 | 16.93 | 12.28 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 171.17 | 164.54 | 152.30 | 121.18 | 109.98 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 171.17 | 164.54 | 152.30 | 121.18 | 109.98 | |
| Dividend / Share(Rs.) | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 119.13 | 135.58 | 108.99 | 94.50 | 90.16 | |
| PBDIT/Share (Rs.) | 17.92 | 22.24 | 21.03 | 20.69 | 16.65 | |
| PBIT/Share (Rs.) | 12.44 | 16.72 | 16.01 | 15.97 | 14.58 | |
| PBT/Share (Rs.) | 10.05 | 13.28 | 13.70 | 14.82 | 13.71 | |
| Net Profit/Share (Rs.) | 7.43 | 10.46 | 11.86 | 12.20 | 10.22 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 15.04 | 16.40 | 19.29 | 21.89 | 18.46 | |
| PBIT Margin (%) | 10.44 | 12.33 | 14.69 | 16.89 | 16.17 | |
| PBT Margin (%) | 8.43 | 9.79 | 12.57 | 15.68 | 15.20 | |
| Net Profit Margin (%) | 6.23 | 7.71 | 10.88 | 12.91 | 11.33 | |
| Return on Networth / Equity (%) | 4.34 | 6.35 | 7.78 | 10.06 | 9.29 | |
| Return on Capital Employed (%) | 7.17 | 10.03 | 10.31 | 12.61 | 12.52 | |
| Return on Assets (%) | 3.22 | 4.51 | 5.42 | 6.60 | 6.48 | |
| Total Debt/Equity (X) | 0.13 | 0.14 | 0.13 | 0.16 | 0.13 | |
| Asset Turnover Ratio (%) | 0.52 | 0.60 | 0.55 | 0.55 | 57.22 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.12 | 1.85 | 1.96 | 1.70 | 1.84 | |
| Quick Ratio (X) | 1.26 | 1.13 | 1.40 | 1.32 | 1.74 | |
| Inventory Turnover Ratio (X) | 2.49 | 2.01 | 2.27 | 3.46 | 21.17 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 9.51 | 8.43 | 8.19 | 4.89 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 6.23 | 5.92 | 5.90 | 4.07 | |
| Earnings Retention Ratio (%) | 0.00 | 90.49 | 91.57 | 91.81 | 95.11 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 93.77 | 94.08 | 94.10 | 95.93 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 636.10 | 502.06 | 833.08 | 806.92 | 666.62 | |
| EV/Net Operating Revenue (X) | 4.20 | 2.91 | 6.04 | 6.99 | 6.05 | |
| EV/EBITDA (X) | 27.92 | 17.76 | 31.31 | 31.92 | 32.78 | |
| MarketCap/Net Operating Revenue (X) | 4.04 | 2.83 | 6.01 | 6.81 | 5.92 | |
| Retention Ratios (%) | 0.00 | 90.48 | 91.56 | 91.80 | 95.10 | |
| Price/BV (X) | 2.81 | 2.33 | 4.30 | 5.31 | 4.86 | |
| Price/Net Operating Revenue | 4.04 | 2.83 | 6.01 | 6.81 | 5.92 | |
| Earnings Yield | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y
26.11.2025
Medicamen Bio Consolidated September 2025 Net Sales at Rs 47.17 crore, up 5.42% Y-o-Y
24.11.2025
Medicamen Bio Standalone September 2025 Net Sales at Rs 42.23 crore, down 1.44% Y-o-Y
09.09.2025
Medicamen Bio Standalone June 2025 Net Sales at Rs 38.45 crore, down 7.31% Y-o-Y
11.06.2025
Medicamen Bio Standalone March 2025 Net Sales at Rs 26.00 crore, down 42.24% Y-o-Y